North of England evidence based guidelines development project: Summary version of evidence based guideline for the primary care management of asthma in adults

British Medical Journal

Volumn 312, Issue 7033, 1996, Pages 762-766

  Eccles, Martin ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; STEROID;

ACUPUNCTURE; AEROSOL; ARTICLE; ASTHMA; DRUG DELIVERY SYSTEM; HUMAN; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT REFERRAL; PEAK EXPIRATORY FLOW; PRACTICE GUIDELINE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SMOKING CESSATION; UNITED KINGDOM; YOGA;

ACUTE DISEASE; ADRENERGIC BETA-ANTAGONISTS; ADULT; ANTI-INFLAMMATORY AGENTS; ASTHMA; CHRONIC DISEASE; DRUG THERAPY, COMBINATION; HUMANS; NEBULIZERS AND VAPORIZERS; PATIENT EDUCATION; SMOKING CESSATION; STEROIDS;

EID: 0029927451     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. North of England Asthma Guideline Development Group. North of England evidence based guideline development project: evidence based guideline for the primary care management of recurrent wheeze in adults. Newcastle upon Tyne: Centre for Health Services Research, 1995.
2. Eccles M, Clapp Z, Grimshaw J, Adams PC, Higgins B, Purves I, et al. North of England evidence based guidelines development project: methods of guideline development. BMJ 1996;312:760-2.
3. British Thoracic Society, British Paediatric Association, Royal College of Physicians, King's Fund Centre, National Asthma Campaign, Royal College of General Practitioners, General Practitioners in Asthma Group, British Association of Accident and Emergency Medicine, British Paediatric Respiratory Group. Guidelines on the management of asthma. Thorax 1993;48:S1-24.
4. Higgins BG, Britton JR, Chinn S, Jones TD, Jenkinson D, Burney PGJ, et al. The distribution of peak expiratory flow variability in a population sample. Am Rev Respir Dis 1989;140:1368-72.
5. Quackenboss JJ, Lebowitz MD, Krzyzanowski M. Normal range of diumal changes in peak expiratory flow rates: relationship to symptoms and respiratory disease. Am Rev Respir Dis 1991;143:323-30.
6. Grampian Asthma Study of Integrated Care (GRASSIC). Effectiveness of routine self monitoring of peak flow in patients with asthma. BMJ 1994;308:564-7.
7. Bellia V, Cibella F, Migliara G, Peralta G, Bonsignore G. Characteristics and prognostic value of morning dipping of peak expiratory flow rate in stable asthmatic subjects. Chest 1985;88:89-93.
8. Nowak RM, Pensier MI, Sarkar DD, Anderson JA, Kvale PA, Ortiz AE, et al. Comparison of peak expiratory flow and FEV1 admission criteria for acute bronchial asthma. Ann Emerg Med 1992;11:64-9.
9. British Medical Association, Royal Pharmaceutical Society of Great Britain. British National Formulary. No 30. London: BMA, RPSGB, 1995.
10. Orgel HA, Meltzer EO, Welch MJ, Kemp JP. Inhaled albuterol powder for the treatment of asthma - a dose-response study. J Allergy Clin Immunol 1985;75:468-71.
11. Taylor DR, Sears MR, Herbison GP, Flannery EM, Print CG, Lake DC, et al. Regular inhaled beta agonist in asthma: effects on exacerbations and lung function. Thorax 1993;48:134-8.
12. Chapman KR, Kesten S, Szalai JP. Regular vs as-needed inhaled salbutamol in asthma control. Lancet 1994;343:1379-82.
13. Rohr AS, Siegel SC, Katz RM, Rachelefsky GS, Spector SL, Lanier R. A comparison of inhaled albuterol and cromolyn in the prophylaxis of exercise-induced bronchospasm. Ann Allergy 1987;59:107-9.
14. 2 agonist. BMJ 1990;301:1365-8.
15. Palmer JB, Stuart AM, Shepherd GL, Viskum K. Inhaled salmeterol in the treatment of patients with moderate to severe reversible obstructive airways disease - a 3-month comparison of the efficacy and safety of twice-daily salmeterol (100 micrograms) with salmeterol (50 micrograms). Respir Med 1992;86:409-17.
16. Bronsky EA, Kemp JP, Orgel HA, Bierman WC, van As A, Liddle RF, et al. A 1-week dose-ranging study of inhaled salmeterol in patients with asthma. Chest 1994;105:1032-7.
17. Pearlman DS, Cheminsky P, LaForce C, Seltzer JM, Southern DL, Kemp JP, et al. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. N Engl J Med 1992;327:1420-5.
18. Britton MG, Earnshaw JS, Palmer JB, on behalf of a European Study Group. A twelve month comparison of salmeterol with salbutamol in asthmatic patients. Eur Respir J 1992;5:1062-7.
19. Lundback B, Rawlinson DW, Palmer JB, on behalf of a European Study Group. Twelve month comparison of salmeterol and salbutamol as dry powder formulation in asthmatic patients. Thorax 1993;48:148-53.
20. Castle W, Fuller R, Hall J, Palmer J. Serevent nationwide surveillance study: comparison of salmeterol with salbutamol in asthmatic patients who require regular bronchodilator treatment. BMJ 1993;306:1034-7.
21. Bergmann KC, Bauer CP, Overlack A. A placebo-controlled, blind comparison of nedoctomil sodium and beclomethasone dipropionate in bronchial asthma. Curr Med Res Opin 1989;11:533-42.
22. Salmeron S, Guerin JC, Godard P, Dominique R, Henry-Amar M, Duroux P, et al. High doses of inhaled corticosteroids in unstable, chronic asthma: a multi-center, double-blind, placebo-controlled study. Am Rev Respir Dis 1989;140:167-71.
23. Haahtela T, Jarvinen M, Kava T, Kiviranta K, Koskinen S, Lehtonen K, et al. Comparison of a bets 2-agonist, terbutaline, with an inhaled corticosteroid, budesonide, in newly detected asthma. N Engl J Med 1991;325:388-92.
24. British Thorosis and Tuberculosis Association. Inhaled corticosteriods compared with oral prednisone in patients starting long-term corticosteroid therapy for asthma. Lancet 1975;ii:469-73.
25. BritishThorasis and Tuberculosis Association. A controlled trial of inhaled corticosteriods in patients receiving prednisone tablets for asthma. Br J Dis Chest 1976;70:95-103.
26. Laursen LC, Taudorf E, Weeke B. High-dose inhaled budesonide in treatment of scure steroid-dependent asthma. Eur J Respir Dis 1986;68: 19-28.
27. Hummel S, Lehtonan L. Comparison of oral-steroid sparing by high-dose and low-dose inhaled steroid in maintenance treatment of severe asthma. Lancet 1992;340:1483-7.
28. Willey RF, Godden DJ, Carmichael J, Preston P, Frame M, Crompton GK. Comparison of twice daily administration of a new corticosteroid budesonide with beclomethazone dipropionate four times daily in the treatment of chronic asthma. Br J Dis Chest 1982;76:61-8.
29. Ebden P, Jenkins A, Houston G, Davies BH. Comparison of two high dose corticosteriod aerasol treatments, beclomethasone dipropionate (1500 micrograms/day) and budesonide (1600 micrograms/day), for chronic asthma. Thorax 1986;41:869-74.
30. Svendsen UG, Frolund L, Heinig JH, Madsen F, Nielsen NH, Weeke B. High-dose inhaled steroids in the management of asthma. A comparison of the effects of budesonide and beclomethasone dipropionate on pulmonary function, symptoms bronchial responsiveness and the adrenal function. Allergy 1992;47:174-89.
31. Barnes NC, Marone G, Di Maria GU, Visser S, Utama I, Payne SL, on behalf of an International Study Group. A companson of fluticasone propionate, 1 mg daily, with beclomethazone dipropionate, 2 mg daily, in the treatment of severe asthma. Eur Respir J 1993;6:877-85.
32. Dahl R, Lundback, B, Malo JL, Mazza JA, Nieminen MM, Saarelainen P, et al, on behalf of an International Study Group. A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. Chest 1993;104:1352-8.
33. Fabbri L, Burge PS, Croonenborgh L, Warlies F, Ciaccia A, Parker C, et al, on behalf of an International Study Group. Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. Thorax 1993;48:817-23.
34. Lundback B, Alexander M, Day J, Hebert J, Holzer R, Van Ufelen R, et al. Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurised inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurised inhaler. Respir Med 1993;87:609-20
35. Lorentzson S, Boe J, Eriksson G, Persson G. Use of inhaled corticosteroids in patients with mild asthma. Thorax 1990;45:733-5.
36. Toogood JH, Basherville JC, Jennings B, Lefcoe NM, Johansson SA. Influence of dozing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide. J Allergy Clin Immunol 1982;70:388-98.
37. Boyd G, Abdallah S, Clark R. Twice or four times daily beclomethasone dipropionate in mild stable asthma? Clin Allergy 1985;15:383-9.
38. Stiksa G, Glennow C. Once daily inhalation of budesonide in the treatment of chronic asthma. A clinical comparison. Ann Allergy 1985;5:49-51.
39. Munch EP, Taudorf E, Weeke B. Dose frequency in the treatment of asthmatics with inhaled topical steroid. Eur J Respir Dis 1982;63(suppl 122):143-5.
40. Gagnon M, Cote J, Milot J, Turcotte H, Boulet LP. Comparative safety and efficacy of single or twice daily administration of inhaled beclomethasone in moderate asthma. Chest 1994;105:1732-7.
41. Wong CS, Couper S, Britton JR, Tattersfield AE. Steroid-sparing effect of nedocromil sodium in asthmatic-patients on high-doses of inhaled steroids. Clin Exp Allergy 1993;23:370-6.
42. Chatterjee PC, Fyane PG, Chatterjee SS. A trial comparing nedocromil sodium (Tilade) and placebo in the management of perennial bronchial-asthma. Eur J Respir Dis 1986;69:314-6.
43. Cua-Lim F, Agbayani BF, Lachica D. A double-blind comparative trial of nedocromil sodium and placebo in the management of bronchial asthma in patients routinely using oral bronchodilators. Eur J Respir Dis 1986; 69(suppl 147):306-10.
44. Greco DB, Negreiros EB, Chaieb JA, Ferreiralima P, Croce J. A multicenter double-blind group comparative trial of 2 dose levels of nedocromil sodium and placebo in the management of perennial extrinsic asthma. Eur J Respir Dis 1986;69:323-6.
45. van As A, Chick TW, Bodman SF, Storms WW, Nathan RA, Selner JC, et al. A group comparative study of the safety and efficacy of nedocromil sodium (Tilade) in reversible airways disease: a preliminary report. Eur J Respir Dis 1986;69(suppl 147):143-8.
46. Edwards AM, Stevens MT. The clinical efficacy of inhaled nedocromil sodium (Tilade) in the treatment of asthma. Eur Respir J 1993;6:35-41.
47. Blumenthal MN, Selcow J, Spector S, Zeiger RS, Mellon M. A multicenter evaluation of the clinical benefits of cromolyn sodium aerosol by metered-dose inhaler in the treatment of asthma. J Allergy Clin Immunol 1988;81: 681-7.
48. Boldy DA, Ayres JG. Nedocromil sodium and sodium cromoglycate in patients aged over 50 years with asthma. Respir Med 1993;87:517-23.
49. Woodman K, Bremner P, Burgess C, Crane J, Pearce N, Beasley R. A comparative study of the efficacy of beclomethasone dipropionate delivered from a breath activated and conventional metered dose inhaler in asthmatic patients. Curr Med Res Opin 1993;13:61-9.
50. Toogood JH, Baskerville J, Jennings B, Lefcoe NM, Johansson S. Use of spacers to facilitate inhaled corticosteroid treatment of asthma. Am Rev Respir Dis 1984;129:723-9.
51. Colacone A, Afilalo M, Wolkove N, Kreisman H. A companson of albuterol administered by matered dose inhaler (and holding chamber) or wet nebulizer in acute asthma. Chest 1993;104:835-41.
52. De Blaquisse P, Christensen DB, Carter WB, Martin TR. Use and misuse of metered-dose inhalers by patients with chronic lung disease. A controlled, randomized trial of two instruction methods. Am Rev Respir Dis 1989;140: 910-6.
53. Neville RG, Crombie IK, McDevitt DG. A double-blind placebo-controlled trial of theophylline in general practice. Br J Clin Pract 1991;45:14-7.
54. Pierson WE, LaForce CF, Bell TD, MacCosbe PE, Sykes RS, Tinkelman D. Long-term, double-blind comparison of controlled-release albuterol versus sustained-release theophylline in adolescents and adults with asthma. J Allergy Clin Immunol 1990;85:618-26.
55. Billing B, Dahlqvist R, Hornblad Y, Leideman T, Skareke L, Ripe E. Theophylline in maintenance treatment of chronic asthma: concentration-dependent additional effect to beta 2-agonist therapy. Eur J Respir Dis 1987;70:35-43.
56. Beskow R, Ericsson CH, Gronneberg R, Sjogren I, Skedinger M. A comparison of sustained-release terbutaline with ordinary salbutamol in bronchial asthma. Eur J Respir Dis 1984;65:509-11.
57. Dahl R, Pedersen B, Hagglof B. Nocturnal asthma: effect of treatment with oral sustained-release terbutaline, inhaled budesonide, and the two in combination. J Allergy Clin Immunol 1989;83:811-5.
58. Vilsvik JS, Langaker O, Persson G, Ringdal N, Schaanning J, Kvelstad G, et al. Bambuterol: a new long acting bronchodilating prodrug. Ann Allergy 1991;66:315-9.
59. Fugloholm AM, Ibsen TB, Laxmyr L, Svendsen UG. Therapeutic equivalance between bambuterol, 10 mg once daily, and terbutaline controlled release, 5 mg twice daily, in mild to moderate asthma. Eur Respir J 1993;6:1474-8.
60. Persson G, Gnosspelius Y, Anehus S. Comparison between a new once-daily, bronchodilating drug, bambuterol, and terbutaline sustained-release, twice daily. Eur Respir J 1988;1:223-6.
61. Rowe BH, Kellev JL, Oxman DA. Effectiveness of steroid therapy in acute exacerbations of asthma: a meta analysis. Am J Emerg Med 1992;10:301-10.
62. Carson JL, Strom BL, Schinnar R, Duff A, Sim E. The low risk of upper gastrointestinal bleeding in patients dispensed corticosteroids. Am J Med 1991;91:223-8.
63. Littenberg B. Aminophylline treatment in severe, acute asthma. A metaanalysis. JAMA 1988;259:1678-84.
64. Wrenn K, Slovis CM, Murphy F, Greenberg RS. Aminophylline therapy for acute bronchospastic disease in the emergency room. Ann Intern Med 1991;115:241-7.
65. Murphy DG, McDermott MF, Rydman RJ, Sloan EP, Zalenski RJ. Aminophylline in the treatment of acute asthma when beta 2-adrenergics and steroids are provided. Arch Intern Med 1993;153:1784-8.
66. Salmeron S, Brochard L, Mal H, Tenaillon A, Henry-Amar M, Renon D, et al. Nebulized versus intravenous albuterol in hypercapnic acute asthma. A multicenter, double-blind, randomized study. American Journal of Respiratory and Critical Care Medicine 1994;149:1466-70.
67. Tasbkin DP, Kroening RJ, Bresler DE, Simmons M, Coulson AH, Kerschnar H. A controlled trial of real and simulated acupuncture in the management of chronic asthma. J Allergy Clin Immunol 1985;76:855-64.
68. Singh V, Wisniewski A, Britton J, Tattersfield A. Effect of yoga breathing exercises (pranayama) on airway reactivity in subjects with asthma. Lancet 1990;335:1381-3.
69. Kleijnen J, ter Riet G, Knipschild P. Acupuncture and asthma: a review of controlled trials. Thorax 1991;46:799-802.
70. Silagy C, Mant D, Fowler G, Lodge M. Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 1994;343:139-42.
71. Tang JL, Law M, Wald N. How effective is nicotine replacement therapy in helping people to stop smoking? BMJ 1994;308:21-6.
72. Hilton S, Sibbald B, Anderson HR, Freeling P. Controlled evaluation of the effects of patient education on asthma morbidity in general practice. Lancet 1986:i:26-9.
73. Jenkinson D, Davison J, Jones S, Hawtin P. Comparison of effects of a self management booklet and audiocassette for patients with asthma. BMJ 1988;297:267-70.
74. Bailey WC, Richards JM Jr, Brooks CM, Soong SJ, Windsor RA, Manzella BA. A randomized trail to improve self-management practices of adults with asthma. Arch Interm Med 1990;150:1664-8.
75. Windsor RA, Bailey WC, Richards JM Jr, Mancella B, Soong SJ, Brooks M. Evaluation of the efficacy and cost effectiveness of health education methods to increases medication adherence among adults with asthma. Am J Public Health 1990;80:1519-21.
76. Wilson SR, Scamagas P, German DF, Hughes GW, Lulla S, Coss S, et al. A controlled trial of two forms of self-management education for adults with asthma. Am J Med 1993;94:564-76.
77. Osman LM, Abdalla MI, Beattie JAG, Ross S, Russell IT, Friend JA, et al. Reducing hospital admission through computer supported education for asthma patients. BMJ 1994;308:568-71.